Noah L. Rosenberg

Chief Medical Officer, Esperion Therapeutics.

Companies

Verrica Pharmaceuticals Inc.CMO Mar 26, 2025 to now¹
Travere Therapeutics, Inc.Chief Medical Officer Jul 30, 2018 to Aug 17, 2021²
Esperion TherapeuticsChief Medical Officer Jun 25, 2013 to Jul 25, 2013³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Verrica Pharmaceuticals Inc. VRCA8,587 shares⁴$32.7K at $3.81Aug 18, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Aug 18, 2026Bought 2,030 shares at $4.92 of Verrica Pharmaceuticals Inc.⁴
Aug 17, 2026Bought 4,200 shares at $4.91 of Verrica Pharmaceuticals Inc.⁴
Nov 25, 2025Bought 2,357 shares at $4.24 of Verrica Pharmaceuticals Inc.⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARVerrica Pharmaceuticals Inc., CMO
2
SEC EDGARTravere Therapeutics, Inc., Chief Medical Officer
3
SEC EDGAREsperion Therapeutics, Chief Medical Officer
4
SEC EDGARVerrica Pharmaceuticals Inc. shares after the filing of Aug 18, 2026
5
SEC EDGARForm 4 filed Nov 25, 2025